Literature DB >> 11705290

Hemodynamic effects of angiotensin II in the kidney.

A Toke1, T W Meyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705290     DOI: 10.1159/000060155

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  5 in total

1.  The role of urinary TGF-β₁, TNF-α, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves.

Authors:  Ankur Mandelia; Minu Bajpai; Sandeep Agarwala; Arun K Gupta; Rakesh Kumar; Abid Ali
Journal:  Pediatr Nephrol       Date:  2013-06-08       Impact factor: 3.714

Review 2.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

Review 3.  Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.

Authors:  Hassan Askari; Nima Sanadgol; Asaad Azarnezhad; Amir Tajbakhsh; Hossein Rafiei; Ali Reza Safarpour; Seyed Mohammad Gheibihayat; Ehsan Raeis-Abdollahi; Amir Savardashtaki; Ali Ghanbariasad; Navid Omidifar
Journal:  Heliyon       Date:  2021-01-20

4.  Plasma renin activity: An early marker of progressive renal disease in posterior urethral valves.

Authors:  Minu Bajpai; Amit Singh
Journal:  J Indian Assoc Pediatr Surg       Date:  2013-10

5.  Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease.

Authors:  Yanling Zhang; Kerri Thai; David M Kepecs; Richard E Gilbert
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.